Skip to main content

Find Clinical Trials

Home
Conditions
Hematologic Neoplasms

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

239 public trials 47 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Completed

Decitabine in Treating Patients With Melanoma or Other Advanced Cancer

NCT00002980

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations: Beckman Research Institute, City of Hope Duarte, California, United States

USC/Norris Comprehensive Cancer Center Los Angeles, California, United States

Los Angeles County-University of Southern California Medical Center Los Angeles, California, United States

University of California Davis Cancer Center Sacramento, California, United States

View Trial Details

Completed

Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders

NCT00114257

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +46 more
Locations: M.D. Anderson Cancer Center at University of Texas Houston, Texas, United States

View Trial Details

Completed

Tipifarnib in Treating Patients With Advanced Hematologic Cancer

NCT00005967

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +68 more
Locations: University of Chicago Cancer Research Center Chicago, Illinois, United States

View Trial Details

Completed

Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction

NCT00025415

Conditions: AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, Accelerated Phase Chronic Myelogenous Leukemia, +170 more
Locations: University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer

NCT00003451

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations: Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States

View Trial Details

Completed

St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer

NCT00005805

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment

NCT00008359

Conditions: Adnexal Diseases, Agranulocytosis, Amyloidosis, +141 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders

NCT00005622

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +56 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Completed

Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer

NCT00296023

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +64 more
Locations: Alta Bates Comprehensive Cancer Center Berkeley, California, United States

UCSF Comprehensive Cancer Center San Francisco, California, United States

View Trial Details

Completed

Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant

NCT00110045

Conditions: Adnexal Diseases, Amyloidosis, Ataxia, +137 more
Locations: CHU Liege - Domaine Universitaire du Sart Tilman Liège, Belgium

Centre Hospitalier Universitaire Henri Mondor Créteil, France

Hopital Edouard Herriot - Lyon Lyon, France

Hopital Saint-Louis Paris, France

View all 13 locations

View Trial Details